Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer.
Hou G, Zheng Y, Wei D, Li X, Wang F, Tian J, Zhang G, Yan F, Zhu Z, Meng P, Yuan J, Gao M, Li Z, Zhang B, Xing Z, Yuan J.
Hou G, et al. Among authors: yan f.
Medicine (Baltimore). 2019 Sep;98(39):e17197. doi: 10.1097/MD.0000000000017197.
Medicine (Baltimore). 2019.
PMID: 31574827
Free PMC article.